Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes

Por Kruger, Dinja T., Opdam, Mark, Sanders, Joyce, van der Noort, Vincent, Boven, Epie, Linn, Sabine C.
Publicado no APMIS (2020)

Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences

Por Kruger, Dinja T., Beelen, Karin J., Opdam, Mark, Sanders, Joyce, van der Noort, Vincent, Boven, Epie, Linn, Sabine C.
Publicado no Br J Cancer (2018)

Postlaryngectomy prosthetic voice rehabilitation outcomes in a consecutive cohort of 232 patients over a 13‐year period

Por Petersen, Japke F., Lansaat, Liset, Timmermans, Adriana J., van der Noort, Vincent, Hilgers, Frans J. M., van den Brekel, Michiel W. M.
Publicado no Head Neck (2019)

IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer

Por Kruger, Dinja T., Alexi, Xanthippi, Opdam, Mark, Schuurman, Karianne, Voorwerk, Leonie, Sanders, Joyce, van der Noort, Vincent, Boven, Epie, Zwart, Wilbert, Linn, Sabine C.
Publicado no Int J Cancer (2019)

PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane

Por Kruger, Dinja T., Opdam, Mark, van der Noort, Vincent, Sanders, Joyce, Nieuwenhuis, Michiel, de Valk, Bart, Beelen, Karin J., Linn, Sabine C., Boven, Epie
Publicado no J Cancer Res Clin Oncol (2020)

Optimizing Survival Predictions of Hypopharynx Cancer: Development of a Clinical Prediction Model

Por Arends, Coralie R., Petersen, Japke F., van der Noort, Vincent, Timmermans, Adriana J., Leemans, C. René, de Bree, Remco, van den Brekel, Michiel W.M., Stuiver, Martijn M.
Publicado no Laryngoscope (2019)

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions

Por Hummelink, Karlijn, Muller, Mirte, Linders, Theodora C., van der Noort, Vincent, Nederlof, Petra M., Baas, Paul, Burgers, Sjaak, Smit, Egbert F., Meijer, Gerrit A., van den Heuvel, Michel M., van den Broek, Daan, Monkhorst, Kim
Publicado no ERJ Open Res (2019)

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

Por de Jong, Evelyn E. C., van Elmpt, Wouter, Leijenaar, Ralph T. H., Hoekstra, Otto S., Groen, Harry J. M., Smit, Egbert F., Boellaard, Ronald, van der Noort, Vincent, Troost, Esther G. C., Lambin, Philippe, Dingemans, Anne-Marie C.
Publicado no Eur J Nucl Med Mol Imaging (2016)

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

Por Brouns, Anita J. W. M., Hendriks, Lizza E. L., van der Noort, Vincent, van de Borne, Ben E. E. M, Schramel, Franz M. N. H., Groen, Harry J. M., Biesma, Bonne, Smit, Hans J. M., Dingemans, Anne-Marie C.
Publicado no Front Oncol (2020)

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer

Por Theelen, Willemijn SME, Mittempergher, Lorenza, Willems, Stefan M, Bosma, Astrid J, Peters, Dennis DGC, van der Noort, Vincent, Japenga, Eva J, Peeters, Ton, Koole, Koos, Šuštić, Tonći, Blaauwgeers, JL, van Noesel, Carel J, Bernards, René, van den Heuvel, Michel M
Publicado no J Pathol Clin Res (2016)

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer: Results of the PEMBRO-RT...

Por Theelen, Willemijn S. M. E., Peulen, Heike M. U., Lalezari, Ferry, van der Noort, Vincent, de Vries, Jeltje F., Aerts, Joachim G. J. V., Dumoulin, Daphne W., Bahce, Idris, Niemeijer, Anna-Larissa N., de Langen, Adrianus J., Monkhorst, Kim, Baas, Paul
Publicado no JAMA Oncol (2019)

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Por Sobral-Leite, Marcelo, Salomon, Izhar, Opdam, Mark, Kruger, Dinja T., Beelen, Karin J., van der Noort, Vincent, van Vlierberghe, Ronald L. P., Blok, Erik J., Giardiello, Daniele, Sanders, Joyce, Van de Vijver, Koen, Horlings, Hugo M., Kuppen, Peter J. K., Linn, Sabine C., Schmidt, Marjanka K., Kok, Marleen
Publicado no Breast Cancer Res (2019)

A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population

Por Badrising, Sushil K., Louhanepessy, Rebecca D., van der Noort, Vincent, Coenen, Jules L.L.M., Hamberg, Paul, Beeker, Aart, Wagenaar, Nils, Lam, Marnix G.E.H., Celik, Filiz, Loosveld, Olaf J.L., Oostdijk, Ad, Zuetenhorst, Hanneke, Haanen, John B., Vegt, Erik, Zwart, Wilbert, Bergman, Andries M.
Publicado no Int J Cancer (2020)

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

Por Dammeijer, Floris, De Gooijer, Cornedine J., van Gulijk, Mandy, Lukkes, Melanie, Klaase, Larissa, Lievense, Lysanne A., Waasdorp, Cynthia, Jebbink, Merel, Bootsma, Gerben P., Stigt, Jos A., Biesma, Bonne, Kaijen-Lambers, Margaretha E.H., Mankor, Joanne, Vroman, Heleen, Cornelissen, Robin, Baas, Paul, Van der Noort, Vincent, Burgers, Jacobus A., Aerts, Joachim G.
Publicado no EBioMedicine (2021)

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

Por Groen, Harry J. M., van der Heijden, Erik H. F. M., Klinkenberg, Theo J., Biesma, Bonne, Aerts, Joachim, Verhagen, Ad, Kloosterziel, Corinne, Pieterman, Remge, van den Borne, Ben, Smit, Hans J. M., Hoekstra, Otto, Schramel, Frans M. N. H., van der Noort, Vincent, van Tinteren, Harm, Smit, Egbert F., Dingemans, Anne-Marie C.
Publicado no Br J Cancer (2019)